Page 76 - JSOM Spring 2020

casualty critical care. J Trauma Acute Care Surg. 2013;75(2 suppl myoblast proliferation, apoptosis, adhesiveness, migration, and
2):S120–S128; discussion S128–S129. invasiveness. Functional inactivation of RAGE in L6 myoblasts
17. Batchinsky AI, Skinner JE, Necsoiu C, et al. New measures of results in tumor formation in vivo. J Biol Chem. 2006;281(12):
heart-rate complexity: effect of chest trauma and hemorrhage. J 8242–8253.
Trauma. 2010;68(5):1178–1185. 42. Limana F, Germani A, Zacheo A, et al. Exogenous high- mobility
18. Isbell CL, Batchinsky AI, Hetz KM, et al. Correlation between group box 1 protein induces myocardial regeneration after infarc-
capnography and arterial carbon dioxide before, during, and af- tion via enhanced cardiac C-kit+ cell proliferation and differenti-
ter severe chest injury in swine. Shock. 2012;37(1):103–109. ation. Circ Res. 2005;97(8):e73–e83.
19. Noe DA, Weedn V, Bell WR. Direct spectrophotometry of serum 43. Tang D, Kang R, Zeh HJ 3rd, et al. High-mobility group box 1
hemoglobin: an Allen correction compared with a three-wave- and cancer. Biochim Biophys Acta. 2010;1799(1–2):131–140.
length polychromatic analysis. Clin Chem. 1984;30(5):627–630. 44. Tesniere A, Panaretakis T, Kepp O, et al. Molecular characteris-
20. Castro CY. ARDS and diffuse alveolar damage: a pathologist’s tics of immunogenic cancer cell death. Cell Death Differ. 2008;15
perspective. Semin Thoracic Cardiovasc Surg. 2006;18(1):13–19. (1):3–12.
21. Thompson BT, Guerin C, Esteban A. Should ARDS be renamed dif- 45. Park JS, Gamboni-Robertson F, He Q, et al. High mobility group
fuse alveolar damage? Intensive Care Med. 2016;42(5):653–655. box 1 protein interacts with multiple Toll-like receptors. Am J
22. Sousse LE, Herndon DN, Andersen CR, et al. Pulmonary histo- Physiol Cell Physiol. 2006;290(3):C917–C924.
pathologic abnormalities and predictor variables in autopsies of 46. Rovere-Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an
burned pediatric patients. Burns. 2015;41(3):519–527. endogenous immune adjuvant released by necrotic cells. EMBO
23. Barnes SL, Branson R, Gallo LA, et al. En-route care in the air: Rep. 2004;5(8):825–830.
snapshot of mechanical ventilation at 37,000 feet. J Trauma. 47. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of
2008;64(2 suppl):S129-S134; discussion S134–S125. endotoxin lethality in mice. Science. 1999;285(5425):248–251.
24. Johannigman J, Gerlach T, Cox D, et al. Hypoxemia during aero- 48. Gardella S, Andrei C, Ferrera D, et al. The nuclear protein
medical evacuation of the walking wounded. J Trauma Acute HMGB1 is secreted by monocytes via a non-classical, vesicle-
Care Surg. 2015;79(4 suppl 2):S216–S220. mediated secretory pathway. EMBO Rep. 2002;3(10):995–1001.
25. VanPatten S, Al-Abed Y. High mobility group box-1 (HMGb1): 49. Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyper-
current wisdom and advancement as a potential drug target. J acetylate chromatin protein HMGB1 to redirect it towards secre-
Med Chem. 2018;61(12):5093–5107. tion. EMBO J. 2003;22(20):5551–5560.
26. Sirisinha S. Insight into the mechanisms regulating immune ho- 50. Haruma J, Teshigawara K, Hishikawa T, et al. Anti-high mobility
meostasis in health and disease. Asian Pac J Allergy. 2011;29(1): group box-1 (HMGB1) antibody attenuates delayed cerebral va-
1–14. sospasm and brain injury after subarachnoid hemorrhage in rats.
27. Liston A, Masters SL. Homeostasis-altering molecular processes Sci Rep. 2016;6:37755.
as mechanisms of inflammasome activation. Nat Rev Immunol. 51. Pilzweger C, Holdenrieder S. Circulating HMGB1 and RAGE as
2017;17(3):208–214. clinical biomarkers in malignant and autoimmune diseases. Diag-
28. Manfredi AA, Capobianco A, Esposito A, et al. Maturing den- nostics (Basel). 2015;5(2):219–253.
dritic cells depend on RAGE for in vivo homing to lymph nodes. 52. Wang J, He GZ, Wang YK, et al. TLR4-HMGB1-, MyD88- and
J Immunol. 2008;180(4):2270–2275. TRIF-dependent signaling in mouse intestinal ischemia/reperfu-
29. Muller S, Scaffidi P, Degryse B, et al. New EMBO members’ review: sion injury. World J Gastroenterol. 2015;21(27):8314–8325.
the double life of HMGB1 chromatin protein: architectural factor 53. Kang R, Chen R, Zhang Q, et al. HMGB1 in health and disease.
and extracellular signal. EMBO J. 2001;20(16):4337–4340. Mol Aspects Med. 2014;40:1–116.
30. Rouhiainen A, Imai S, Rauvala H, et al. Occurrence of ampho- 54. Richard SA, Jiang Y, Xiang LH, et al. Post-translational modifica-
terin (HMG1) as an endogenous protein of human platelets that tions of high mobility group box 1 and cancer. Am J Transl Res.
is exported to the cell surface upon platelet activation. Thromb 2017;9(12):5181–5196.
Haemost. 2000;84(6):1087–1094. 55. Aiqi Xi GL. Altitude difference of HMGB1, Fetuin-A in the pa-
31. Wang LJ, Lu L, Zhang FR, et al. Increased serum high-mobility tients with congestive heart failure and effects on ventricular re-
group box-1 and cleaved receptor for advanced glycation end- modeling. Preentation presented at 26th Great Wall International
products levels and decreased endogenous secretory receptor Congress Of Cardiology & Asia Pacific Heart Congress 2015
for advanced glycation endproducts levels in diabetic and non- (GW-ICC APHF 2015); October 29, 2015–November 1, 2015;
diabetic patients with heart failure. Eur J Heart Fail. 2011;13 China National Convention Center Beijing, Beijing, China.
(4):440–449. 56. Koczula KM, Gallotta A. Lateral flow assays. Essays Biochem.
32. Ueno T, Ikeda T, Ikeda K, et al. HMGB-1 as a useful prognostic 2016;60(1):111–120.
biomarker in sepsis-induced organ failure in patients undergoing 57. Gaillard C, Borde C, Gozlan J, et al. A high-sensitivity method
PMX-DHP. J Surg Res. 2011;171(1):183–190. for detection and measurement of HMGB1 protein concentra-
33. Goldstein RS, Gallowitsch-Puerta M, Yang L, et al. Elevated tion by high-affinity binding to DNA hemicatenanes. PLoS One.
high-mobility group box 1 levels in patients with cerebral and 2008;3(8):e2855.
myocardial ischemia. Shock. 2006;25(6):571–574. 58. Sin ML, Gao J, Liao JC, et al. System integration: a major step
34. Ueno H, Matsuda T, Hashimoto S, et al. Contributions of high toward lab on a chip. J Biol Eng. 2011;5:6.
mobility group box protein in experimental and clinical acute lung 59. Omar HR, Mirsaeidi M, Socias S, et al. Plasma free hemoglo-
injury. Am J Respir Crit Care Med. 2004;170(12):1310–1316. bin is an independent predictor of mortality among patients
35. Fu J, Lin SH, Wang CJ, et al. HMGB1 regulates IL-33 expression on extracorporeal membrane oxygenation support. PLoS One.
in acute respiratory distress syndrome. Int immunopharmacol. 2015;10(4).
2016;38:267–274. 60. Sulkowski JP, Cooper JN, Pearson EG, et al. Hemolysis- associated
36. Martin R, Martin GS, Harris F, et al. The rage signaling pathway nitric oxide dysregulation during extracorporeal membrane oxy-
in sepsis induced ARDS: role of Hmgb1 and Mmps. Am J Resp genation. J Extra Corpor Technol. 2014;46(3):217–223.
Crit Care. 2015;191. 61. Vercaemst L. Hemolysis in cardiac surgery patients undergoing
37. Valdes-Ferrer SI, Papoin J, Dancho ME, et al. HMGB1 mediates cardiopulmonary bypass: a review in search of a treatment algo-
anemia of inflammation in murine sepsis survivors. Mol Med rithm. J Extracorp Technol. 2008;40(4):257–267.
(Cambridge, Mass). 2015. 62. Harm SK, Waters JH, Lynn P, et al. Changes in mechanical fra-
38. Lotze MT, Tracey KJ. High-mobility group box 1 protein gility and free hemoglobin levels after processing salvaged cardio-
(HMGB1): nuclear weapon in the immune arsenal. Nat Rev Im- pulmonary bypass circuit blood with a modified ultrafiltration
munol. 2005;5(4):331–342. device. J Extracorp Technol. 2012;44(1):21–25.
39. Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) pro- 63. Donadee C, Raat NJ, Kanias T, et al. Nitric oxide scavenging
tein: friend and foe. Cytokine Growth Factor Rev. 2006;17(3): by red blood cell microparticles and cell-free hemoglobin as a
189–201. mechanism for the red cell storage lesion. Circulation. 2011;124
40. Sundberg E, Fasth AE, Palmblad K, et al. High mobility group (4):465–476.
box chromosomal protein 1 acts as a proliferation signal for acti- 64. Gladwin MT, Kim-Shapiro DB. Storage lesion in banked blood
vated T lymphocytes. Immunobiology. 2009;214(4):303–309. due to hemolysis-dependent disruption of nitric oxide homeosta-
41. Riuzzi F, Sorci G, Donato R. The amphoterin (HMGB1)/recep- sis. Curr Opin Hematol. 2009;16(6):515–523.
tor for advanced glycation end products (RAGE) pair modulates

70 | JSOM Volume 20, Edition 1 / Spring 2020